SOURCE: Antisoma plc

August 06, 2008 10:22 ET

Antisoma to Present at Canaccord Adams 28th Annual Global Growth Conference

LONDON--(Marketwire - August 6, 2008) - Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that its Chief Executive, Glyn Edwards, will be presenting at the Canaccord Adams Annual Global Growth Conference in Boston, MA.

The presentation is scheduled for 08:30 local time (13:30 UK time) on Tuesday, August 12th, and a webcast will be available to all on Antisoma's website at

For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.

Background on Antisoma

With operations in the UK and US, Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised academic or cancer research institutions. Its core activity is the preclinical and clinical development of these drug candidates. Please visit for further information.

Copyright © Hugin AS 2008. All rights reserved.

Contact Information

  • Enquiries:
    Daniel Elger
    Director of Communications
    Antisoma plc
    +44 7909 915 068

    Brian Korb
    The Trout Group
    +1 212 477 9007